HEM-POWR Study APK - v1.2.0

No rating yet

For people with hemophilia A participating in the HEM-POWR study... [readmore]


⇣ Download APK (5.99 MB)

This is an original APK file direct fetch from google play. It is safe to download and free of any virus.

Version 1.2.0
Update
Size 5.99 MB
Category Health & Fitness
Developer MicroHealth Inc
Downloads ↓ 5
⇣ Download APK (5.99 MB)

This is an original APK file direct fetch from google play. It is safe to download and free of any virus.

Basic Infos

License type Free
Version 1.2.0
Size 5.99 MB (6277910)
Filename com.hempowr.hemophilia_120_6277910.apk
Requirement 4.3 and up
Type app
Category Health & Fitness
Package name: com.hempowr.hemophilia
Slogan: For people with hemophilia A participating in the HEM-POWR study

App Permissions (inside APK file)


‣ android.permission.ACCESS_NETWORK_STATE
‣ android.permission.INTERNET
‣ com.microhealth.hemophilia.MHProvider.ACCESS_DATA
‣ android.permission.RECEIVE_BOOT_COMPLETED
‣ android.permission.FOREGROUND_SERVICE
‣ android.permission.POST_NOTIFICATIONS
‣ android.permission.WAKE_LOCK
‣ com.google.android.gms.permission.AD_ID
‣ com.google.android.finsky.permission.BIND_GET_INSTALL_REFERRER_SERVICE


Features used


‣ android.hardware.touchscreen

Screenshots (3 images)

HEM-POWR Study screenshot 1 HEM-POWR Study screenshot 2 HEM-POWR Study screenshot 3

About HEM-POWR Study APK

HEM-POWR Study poster
HEM-POWR Study APK version 1.2.0 poster

Latest update


Hem Powr version 1.0

HEM-POWR Study APK Description


HEM-POWR App is intended solely for the participants in the HEM-POWR study in the United States: Observational Study Evaluating Effectiveness and Safety of Real-World Treatment with Damoctocog alfa pegol in Previously Treated Patients with Hemophilia A.
The purpose of the app is to help the participants to answer the electronic Patient-Reported Outcomes Questionnaires which are part of your participation in the HEM-POWR study.
Utilizing MicroHealth and HEM-POWR App is absolutely voluntary and your decision to use or not use it will neither affect your participation in the HEM-POWR study nor the standard medical care for you / your child.
This tool includes electronic reminders concerning Patient-Reported Outcomes Questionnaires, a personal and password-protected database for entry, and features to permit those involved in the HEM-POWR study to get relevant reports FOR NON-EMERGENCY REASONS ONLY.
If you think you may have a medical emergency, call your doctor or 911 immediately. MicroHealth and HEM-POWR do not recommend or endorse any specific products, physicians, procedures, opinions, or other information that may be mentioned on the Site.

How to install HEM-POWR Study APK for Android


Download HEM-POWR Study APK file (com.hempowr.hemophilia_120_6277910.apk) from APKPure.live, then follow these steps:

Update Phone Settings

  • Go to your phone Settings page
  • Tap Security or Applications (varies with device)
  • Check the Unknown Sources box
  • Confirm with OK

Go to Downloads

  • Open Downloads on your device by going to My Files or Files
  • Tap the APK file you downloaded (com.hempowr.hemophilia_120_6277910.apk)
  • Tap Install when prompted, the APK file you downloaded will be installed on your device.

How to install HEM-POWR Study APK on Windows PC 7/8/10/11 or MAC?


Download HEM-POWR Study APK file (com.hempowr.hemophilia_120_6277910.apk) from APKPure.live to your PC (ex: C://Users/xxx/Downloads/(com.hempowr.hemophilia_120_6277910.apk), then follow these steps appear on screen.

Using Emulator:

  • Download And Install one Emulator Softwares (Ex: Bluestacks, GenyMotion, NoxPlayer)
  • Simple install APK on PC by drag and drop file com.hempowr.hemophilia_120_6277910.apk on Emulator screen

HEM-POWR Study APK Pros & Cons


Pros
  • This app is safe, it's not require high risk permissions
  • Compatible with 32 bit device (most Emulator using 32bit arch CPU)
  • Compatible with 64-bit device (some android device and current Bluestacks)

Cons
Everything is good.


Similar applications


New Apps



Comments

No comment Yet.